Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret Stock
Equities
ANGEN
TREANGN00028
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.23 TRY | -0.24% | +2.17% | -1.77% |
Sales 2021 | 410M 12.72M | Sales 2022 | 269M 8.34M | Capitalization | 4.74B 147M |
---|---|---|---|---|---|
Net income 2021 | 433M 13.43M | Net income 2022 | 330M 10.24M | EV / Sales 2021 | 6.59 x |
Net cash position 2021 | 511M 15.84M | Net cash position 2022 | 411M 12.76M | EV / Sales 2022 | 16.1 x |
P/E ratio 2021 |
5.1
x | P/E ratio 2022 |
14.3
x | Employees | 171 |
Yield 2021 * |
-
| Yield 2022 |
2.76% | Free-Float | 25.33% |
1 day | -0.24% | ||
1 week | +2.17% | ||
Current month | +1.83% | ||
1 month | -15.30% | ||
3 months | -8.11% | ||
6 months | -11.05% | ||
Current year | -1.77% |
Managers | Title | Age | Since |
---|---|---|---|
Elif Akyuz
FOU | Founder | 49 | 10-06-10 |
Alper Akyuz
CEO | Chief Executive Officer | 54 | 10-06-10 |
Director of Finance/CFO | 37 | 20-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Alper Akyuz
CEO | Chief Executive Officer | 54 | 10-06-10 |
Elif Akyuz
FOU | Founder | 49 | 10-06-10 |
Director of Finance/CFO | 37 | 20-11-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-06 | 12.23 | -0.24% | 3 877 914 |
24-06-05 | 12.26 | +0.49% | 3,564,620 |
24-06-04 | 12.2 | +1.24% | 1,353,066 |
24-06-03 | 12.05 | +0.33% | 1,945,606 |
24-05-31 | 12.01 | +0.33% | 1,324,846 |
Delayed Quote Borsa Istanbul, June 06, 2024 at 11:09 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-1.77% | 83.51M | |
+55.55% | 59.34B | |
+43.17% | 40.24B | |
-4.71% | 39.88B | |
-5.56% | 28.55B | |
+13.76% | 27.26B | |
-22.00% | 19.23B | |
+31.50% | 12.61B | |
+2.16% | 12.49B | |
+25.70% | 12.28B |
- Stock Market
- Equities
- ANGEN Stock